# Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery

> **NCT02110654** · PHASE4 · COMPLETED · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 50 (actual)

## Conditions studied

- Sinusitis
- Nasal Polyps
- Asthma

## Interventions

- **DRUG:** Montelukast
- **DRUG:** mometasone furoate nasal spray

## Key facts

- **NCT ID:** NCT02110654
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2020-11-01
- **Final completion:** 2020-11-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02110654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02110654, "Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02110654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*